Developing a new HIV vaccine to enhance immune responses
Design and optimization of DL-NLTs and molecular adjuvants to increase potency and promote NAb formation in vivo
This study is looking for people to help test new HIV vaccines that aim to boost your immune system's ability to fight the virus by using special ingredients that help your body recognize and respond to it better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wistar Institute NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11011258 on NIH RePORTER |
What this research studies
This research focuses on creating innovative vaccine candidates for HIV-1 that can stimulate strong immune responses, including the production of neutralizing antibodies and T cell responses. The approach involves using DNA-launched immunogens that self-assemble in the body to present the right targets for the immune system while avoiding those that could lead to ineffective responses. By combining these immunogens with molecular adjuvants, the research aims to enhance the body's ability to fight HIV effectively. Patients may have the opportunity to participate in clinical trials that test these new vaccine candidates.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals at risk for HIV or those living with HIV who are seeking new treatment options.
Not a fit: Patients who are not at risk for HIV or those who have already achieved viral suppression with existing therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective HIV vaccine that significantly improves immune protection against the virus.
How similar studies have performed: Previous research has shown promise in developing similar vaccine strategies, indicating potential for success in this novel approach.
Where this research is happening
Philadelphia, United States
- Wistar Institute — Philadelphia, United States (Active)
Researchers
- Principal investigator: Weiner, David B. — Wistar Institute
- Study coordinator: Weiner, David B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.